Cargando…

Immunogenicity of a third COVID-19 messenger RNA vaccine dose in primary immunodeficiency disorder patients with functional B-cell defects

Detalles Bibliográficos
Autores principales:	Gernez, Yael, Murugesan, Kanagavel, Cortales, Cristina R., Banaei, Niaz, Hoyte, Lisa, Pinsky, Benjamin A., Lewis, David B., Pham, Michele N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2022
Materias:	Clinical Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897836/ https://www.ncbi.nlm.nih.gov/pubmed/35259538 http://dx.doi.org/10.1016/j.jaip.2022.02.030

Ejemplares similares

Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects
por: Pham, Michele N., et al.
Publicado: (2022)

Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report
por: Ferguson, Jessica, et al.
Publicado: (2021)

SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection
por: Gombar, Saurabh, et al.
Publicado: (2021)

Interferon-γ Release Assay for Accurate Detection of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Response
por: Murugesan, Kanagavel, et al.
Publicado: (2020)

Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy
por: Gernez, Yael, et al.
Publicado: (2018)

Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study
por: Yang, Lu M., et al.
Publicado: (2022)

Genome-wide tiled detection of circulating Mycobacterium tuberculosis cell-free DNA using Cas13
por: Thakku, Sri Gowtham, et al.
Publicado: (2023)

Investigation of Preanalytical Variables Impacting Pathogen Cell-Free DNA in Blood and Urine
por: Murugesan, Kanagavel, et al.
Publicado: (2019)

Microbiologic Diagnosis of Lung Infection
por: Banaei, Niaz, et al.
Publicado: (2016)

Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals
por: Collier, Ai-ris Y, et al.
Publicado: (2021)

Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants
por: Niyomnaitham, Suvimol, et al.
Publicado: (2023)

Light third-generation squarks from flavour gauge messengers
por: Brümmer, Felix, et al.
Publicado: (2013)

Hair Sheep Blood, Citrated or Defibrinated, Fulfills All Requirements of Blood Agar for Diagnostic Microbiology Laboratory Tests
por: Yeh, Ellen, et al.
Publicado: (2009)

Delayed Diagnosis of Tuberculous Meningitis Misdiagnosed as Herpes Simplex Virus-1 Encephalitis With the FilmArray Syndromic Polymerase Chain Reaction Panel
por: Gomez, Carlos A., et al.
Publicado: (2016)

Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience
por: Peled, Yael, et al.
Publicado: (2022)

Livedo reticularis on bilateral knees after the third dose of messenger RNA-1273 SARS-CoV-2 vaccine
por: Mintz, Michelle Amy, et al.
Publicado: (2022)

Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
por: Addeo, Alfredo, et al.
Publicado: (2021)

Perinatally Human Immunodeficiency Virus–Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity( )
por: Morrocchi, Elena, et al.
Publicado: (2022)

Extracellular calcium acts as a “third messenger” to regulate enzyme and alkaline secretion
por: Caroppo, Rosa, et al.
Publicado: (2004)

Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
por: Vergori, Alessandra, et al.
Publicado: (2022)

Letter to the Editor: Immunogenicity After the Third Dose of COVID-19 Vaccine in Cardiac Transplantation
por: Rahman, Afsana, et al.
Publicado: (2023)

Defective control of pre–messenger RNA splicing in human disease
por: Chabot, Benoit, et al.
Publicado: (2016)

Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients
por: Giuliano, Anna, et al.
Publicado: (2023)

Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipients
por: Strauss, Alexandra T., et al.
Publicado: (2022)

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine – An Interim Analysis
por: Anderson, Evan, et al.
Publicado: (2022)

Immunogenicity of a Third Dose of BNT162b2 Vaccine among Lung Transplant Recipients—A Prospective Cohort Study
por: Shostak, Yael, et al.
Publicado: (2023)

Traveler's encounter with nymphs in a hotel bed
por: Sandlund, Johanna, et al.
Publicado: (2014)

Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults
por: Zhang, Yuntao, et al.
Publicado: (2022)

Actin cytoskeletal defects in immunodeficiency
por: Moulding, Dale A, et al.
Publicado: (2013)

Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults
por: Yorsaeng, Ritthideach, et al.
Publicado: (2022)

Analysis of Risk Factors for a Low Immune Response to Messenger RNA COVID-19 Vaccine in Kidney Transplant Recipients and Differences Between Second and Third Dose
por: Panarese, A., et al.
Publicado: (2022)

Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy
por: Syversen, Silje W., et al.
Publicado: (2022)

Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes
por: Tut, Gokhan, et al.
Publicado: (2023)

Challenges faced in the management of complicated Boerhaave syndrome: a tertiary care center experience
por: Harikrishnan, Sakthivel, et al.
Publicado: (2020)

Anti-tumour cytotoxicity of poly(A)-containing messenger RNA isolated from tumour-specific immunogenic RNA.
por: Greenup, C. J., et al.
Publicado: (1978)

neutrinos as messengers
por: Ahlers, Markus
Publicado: (2018)

Zinc messenger
por: Powell, Kendall
Publicado: (2007)

Destroying the messenger
por: Wells, William A.
Publicado: (2007)

Messenger of safety.
por: Clay, R
Publicado: (1998)

Unmasking the messenger
por: Hutten, Saskia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6iodma1bs0qcjefm7obhn4buqu